Uncategorized

Koppy is a senior pharmaceutical business development executive with over 20 years' experience in global biotechnology and pharmaceutical companies in the United States, Europe and Japan. Most recently, she was Vice President of Corporate Development ...
Read more »

NEW YORK (AP) -- Shares of some top biotechnology companies are up at noon: Amgen rose $.40 or .7 percent, to $58.24. Biogen Idec rose $.27 or .5 percent, to $52.37. Celgene rose $.44 or .8 percent, to $58.83. Gilead Sciences rose $.19 or .5 percent, to $40.56.
Read more »

... Governor Mitch Daniels and Secretary of Commerce Mitch Roob will travel to Chicago next week to recruit new high-tech companies to Indiana and showcase the state's strengths in biotechnology. The trip is part of the state's business recruiting ...
Read more »

NEW YORK (AP) -- Shares of some top biotechnology companies are mixed at 10 a.m.: Amgen rose $.01 or percent, to $57.85. Biogen Idec rose $.20 or .4 percent, to $52.30. Celgene rose $.16 or .3 percent, to $58.55. Gilead Sciences fell $.04 or .1 percent, to $40.33.
Read more »

NEW YORK (AP) - Shares of some top biotechnology companies are mixed at 10 a.m.: Amgen rose $.01 or percent, to $57.85. Biogen Idec rose $.20 or .4 percent, to $52.30. Celgene rose $.16 or .3 percent, to $58.55. Gilead Sciences fell $.04 or .1 ...
Read more »

Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a clinical cell line development services company, jointly announced today their collaborative agreement to create a business model enabling customers to access their one stop shop services.
Read more »

The collaboration will enhance and strengthen the clinical development services integrating cDNA synthesis, cloning into mammalian expression vector, transfection, clone selection and stable cell line development seamlessly with cell banking ...
Read more »